NXG NexgenRx Inc.
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.…
Industry Peers
Health Information ServicesKey Statistics
About NexgenRx (CVE: NXG)
›
NexgenRx (CVE: NXG) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.5900 CAD on 19 November 2026, up 51.6% over 52 weeks. Its 52-week range is 0.2900 CAD to 0.7500 CAD: the price is 21.3% below the high and 103.4% above the low.
At a market capitalisation of 41.96M CAD, it trades at 19.7 times trailing earnings. The median trailing P/E of its 15 largest Health Information Services peers is 39.9, a discount of 51% for NXG. It pays a dividend yielding 2.99% (it pays out 48% of its earnings), against a median of 0.53% among the dividend payers in that peer group.
NexgenRx reports return on equity of 16.9%, an operating margin of 18.7% and revenue up 20.8% year over year.
It holds more cash than debt, a net cash position of 3.29M CAD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. The next earnings report is expected on 26 November 2026.